Counts, Debra R <br/><br/>
A 4-Year, Open-Label, Multicenter, Randomized Trial of Genotropin® Growth Hormone in Patients with Idiopathic Short Stature: Analysis of 4-Year Data Comparing Efficacy, Efficiency, and Safety between an Individualized, Target-Driven Regimen and Standard Dosing.  [electronic resource] 

 -  Hormone research in paediatrics  2015 
 - 79-87 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1663-2826 
<br/><br/><label>Standard No.: </label>10.1159/000381642  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Body Height--drug effects<br/>Bone Development--drug effects<br/>Child<br/>Child, Preschool<br/>Cost-Benefit Analysis<br/>Dose-Response Relationship, Drug<br/>Female<br/>Growth Disorders--drug therapy<br/>Human Growth Hormone--administration & dosage<br/>Humans<br/>Male<br/>Parents<br/>Precision Medicine<br/>Recombinant Proteins--therapeutic use<br/>Treatment Outcome